Toxoplasmosis-Associated Hemophagocytic Lymphohistiocytosis in Allogeneic Transplantation

J Clin Immunol. 2021 May;41(4):843-846. doi: 10.1007/s10875-021-00979-8. Epub 2021 Jan 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Disease Management
  • Disease Susceptibility
  • Graft vs Host Disease / diagnosis
  • Graft vs Host Disease / etiology
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Immunosuppression Therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology
  • Lymphohistiocytosis, Hemophagocytic / diagnosis*
  • Lymphohistiocytosis, Hemophagocytic / etiology*
  • Lymphohistiocytosis, Hemophagocytic / therapy
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Toxoplasmosis / complications*
  • Toxoplasmosis / diagnosis
  • Toxoplasmosis / etiology
  • Transplantation, Homologous
  • Treatment Outcome